"Metronidazole" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. It has also been proposed as a radiation sensitizer for hypoxic cells. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985, p133), this substance may reasonably be anticipated to be a carcinogen (Merck, 11th ed).
| Descriptor ID |
D008795
|
| MeSH Number(s) |
D02.640.672.500 D03.383.129.308.658.500
|
| Concept/Terms |
Metronidazole- Metronidazole
- 2-Methyl-5-nitroimidazole-1-ethanol
- 2 Methyl 5 nitroimidazole 1 ethanol
Metronidazole Hydrochloride- Metronidazole Hydrochloride
- Hydrochloride, Metronidazole
- Metronidazole Monohydrochloride
- Monohydrochloride, Metronidazole
Metronidazole Phosphate- Metronidazole Phosphate
- Phosphate, Metronidazole
- Metronidazole Phosphoester
- Phosphoester, Metronidazole
|
Below are MeSH descriptors whose meaning is more general than "Metronidazole".
Below are MeSH descriptors whose meaning is more specific than "Metronidazole".
This graph shows the total number of publications written about "Metronidazole" by people in this website by year, and whether "Metronidazole" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Metronidazole" by people in Profiles.
-
Pramar YV, Mandal TK, Bostanian LA, Le G, Morris TC, Graves RA. Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt. Int J Pharm Compd. 2021 Mar-Apr; 25(2):169-175.
-
Coudray MS, Sheehan DM, Li T, Cook RL, Schwebke J, Madhivanan P. Factors Associated With the Recurrence, Persistence, and Clearance of Asymptomatic Bacterial Vaginosis Among Young African American Women: A Repeated-Measures Latent Class Analysis. Sex Transm Dis. 2020 12; 47(12):832-839.
-
Mahaparale PR, Vinjamuri BP, Chavan MS, Chougule MB, Haware RV. Computational Predictability of Microsponge Properties Using Different Multivariate Models. AAPS PharmSciTech. 2019 Apr 23; 20(5):172.
-
Warrington E, L?pez-Rom?n O, Tirado Montijo R, Urbina R, Cruz-Correa M, Toro DH. Neither 10- nor 14-Day Sequential Treatment is better than Standard Triple Therapy for Helicobacter Pylori Eradication. P R Health Sci J. 2016 12; 35(4):203-208.
-
Salazar CO, Cardenas VM, Reddy RK, Dominguez DC, Snyder LK, Graham DY. Greater than 95% success with 14-day bismuth quadruple anti- Helicobacter pylori therapy: a pilot study in US Hispanics. Helicobacter. 2012 Oct; 17(5):382-90.
-
Ayala G, Galv?n-Portillo M, Chihu L, Fierros G, S?nchez A, Carrillo B, Rom?n A, L?pez-Carrillo L, Silva-S?nchez J. Resistance to antibiotics and characterization of Helicobacter pylori strains isolated from antrum and body from adults in Mexico. Microb Drug Resist. 2011 Jun; 17(2):149-55.
-
Rodr?guez-Torres M, Salgado-Mercado R, R?os-Bedoya CF, Aponte-Rivera E, Marxuach-Cu?tara AM, Rodr?guez-Orengo JF, Fern?ndez-Carbia A. High eradication rates of Helicobacter pylori infection with first- and second-line combination of esomeprazole, tetracycline, and metronidazole in patients allergic to penicillin. Dig Dis Sci. 2005 Apr; 50(4):634-9.
-
Blair RM, Appt SE, Franke AA, Clarkson TB. Treatment with antibiotics reduces plasma equol concentration in cynomolgus monkeys (Macaca fascicularis). J Nutr. 2003 Jul; 133(7):2262-7.
-
Trieber CA, Taylor DE. Mutations in the 16S rRNA genes of Helicobacter pylori mediate resistance to tetracycline. J Bacteriol. 2002 Apr; 184(8):2131-40.
-
Stiles JK, Shah PH, Xue L, Meade JC, Lushbaugh WB, Cleary JD, Finley RW. Molecular typing of Trichomonas vaginalis isolates by HSP70 restriction fragment length polymorphism. Am J Trop Med Hyg. 2000 Apr; 62(4):441-5.